|Title||Marine natural products as potential anti-tubercular agents|
|Publication Type||Journal Article|
|Year of Publication||2019|
|Authors||Hou X.M, Wang C.Y, Gerwick WH, Shao C.L|
|Type of Article||Review|
|Keywords||antimycobacterial metabolites; asymmetric-synthesis; b abeo-sterols; caribbean sea; drug discovery; manzamine alkaloids; marine natural products; marine organisms; mollusk elysia-rufescens; mycobacterium-tuberculosis; Pharmacology & Pharmacy; protein-kinase-g; scleroderris canker fungus; Secondary metabolites; Sponge; Tuberculosis|
Tuberculosis has been one of the greatest global health challenges of all time. Although the current first-line anti-tuberculosis (anti-TB) medicines used in the clinic have reduced mortality, multidrug-resistance and extensively drug-resistance forms of the disease have now spread worldwide and become a global problem. Even so, few new clinically approved drugs have emerged during the past 30 years. Highly biodiverse marine organisms have received considerable attention for drug discovery in the past couple of decades, and emerging TB drug resistance has motivated interest in assessing marine natural products (MNPs) in the treatment of this disease. So far, more than 170 compounds have been isolated from marine organisms with anti-TB properties, ten of which exhibit potent activity and have the potential for further development. This review systematically surveys MNPs with anti-TB activity and illustrates the impact of these compounds on drug discovery research against tuberculosis. (C) 2019 Elsevier Masson SAS. All rights reserved.